BioSpace News Archive

TMC and TMC Labs product review division recently recognized Kyla as an Exceptional Innovation award winner for the 2020 Pandemic Tech Innovation Awards.

Aspen Laser, an emerging leader in photomedicine, announced this week that it has been recognized by MobiHealthNews on its annual listing of the fastest-growing digital health, health IT, medical device, and consumer digital wellness companies found on the Inc. 5000 2020 list.

Through its Stand Up For Clean Air initiative, American Lung Association drives science-based conversations around health impacts of climate change and air pollution to encourage action

Biosensors have developed as the most potential diagnostic devices utilized for the identification of an analyte with the assistance of a physiochemical identifier.

Berkshire Biomedical, LLC (“Berkshire” or “the Company”), a privately-held digital health company developing a revolutionary virtual care and prescription drug management system for the Intended User, today announced that the U.S. Patent and Trademark Office (USPTO) has granted U.S. patent application No. 16/420,002 relating to the Company’s Computerized Prescription Administration (COPA™) system

The EMPOWR Acetabular™ System and EMPOWR Partial Knee™ restore healthy kinematics and promote surgical efficiency with single-tray implantation

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced that the U.S. Food and Drug Administration granted emergency, expanded access approval to treat one “long-hauler” patient on August 1, 2020, and two additional patient approvals on August 17, 2020.

LAIX Inc. (“LAIX” or the “Company”) (NYSE: LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it will report its second quarter 2020 unaudited financial results on Wednesday, August 26, 2020, after the close of the U.S. markets.

Conformis, Inc. (NASDAQ:CFMS) announced today that it completed the second of three milestones pursuant to the License Agreement and Development Agreement with Howmedica Osteonics Corp., a wholly owned subsidiary of Stryker Corporation also known as Stryker Orthopaedics, under which Conformis is developing patient-specific instrumentation (“PSI”) for use in connection with Stryker’s knee implant offerings. The Company will receive an addition

Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced an upcoming late-breaker poster presentation at The Digital International Liver Congress™ 2020 (EASL), which is being held virtually from August 27 to 29. This presentation will discuss key data from A